Clinical Trial Update: Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether natalizumab reduces infarct volume in patients with acute ischemic stroke. The trial has completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Biogen | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED | Results posted: 2016-07-01